Newsletter Signup | Join Community
“This is an exciting time in brain tumor research,” says Harriet Patterson, MPH.
Brain Tumor Advocacy Groups
Kimberly Fowler: Brain Cancer Survivor.
Data Safety and Monitoring Board Recommends Celldex’s Study of RINTEGA® in Newly Diagnosed Glioblastoma Be Discontinued
Symptoms, signs, diagnosis and overview of brain tumors.
Could the Poliovirus be The Next Breakthrough for the Treatment of Brain Cancers?
MD Anderson Researchers Show Risks of Whole Brain Radiation Therapy Added to Radiosurgery Outweigh Benefits In Patients
Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit
UAB first in U.S. to use HyperArc High-Definition Radiotherapy on brain cancer
DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial.
Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment.
Chemotherapy Following Radiation Improves Outcomes in Low Grade Glioblastoma.
Danish Study Suggests Contraceptive Use Increases Risk of Brain Cancer.
Glioblastoma is a particularly aggressive type of brain cancer.
Danish Study Finds No Link Between Cell Phones and Brain Tumors
Follow-Up Study Shows ICT-107 Vaccine Fails to Extend Survival in GBM.
Longer Life for Brain Cancer Patients Who Exercise
Allergies Linked with Lower Risk of Brain Tumor
Avastin Doesn’t Improve Survival in Newly Diagnosed Glioblastoma.
Combination of Radiation and Chemotherapy Improves Survival For Certain Types of Brain Cancer
Children & adolescents who regularly use cell phones do not appear to have a higher risk of brain cancer than non-users.
Repeated Surgeries Improve Survival in Glioblastoma
Glioblastoma Multiforme (GBM) is a devastating disease
Early Resection of Low-Grade Gliomas Improves Survival
High-dose Methotrexate Provides Long-term Results in Central Nervous System Lymphoma
A non-invasive technique that delivers radiation directly to the target.
FDA Approves New Treatment for Glioblastoma Multiforme.
Antiviral Drug May Extend Survival in Glioblastoma
Childhood CT Scans Linked to Leukemia and Brain Cancer Later in Life
Novel Vaccine Prolongs Survival in Glioblastoma Multiforme
No Added Toxicity with Avastin in Glioblastoma
Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial.
Gliadel® Wafer Improves Survival in Aggressive Gliomas
Matthew Zachary: Pediatric Brain Cancer Survivor
Individuals with FAP at Increased Risk of Brain Tumors.
Temodar and Hypofractionated Radiotherapy Appropriate for Elderly Patients with Glioblastoma
Temodar® plus Radiation Improves Survival for Brain Cancer
Rindopepimut with Temodar Appears Promising in Newly Diagnosed Glioblastoma Multiforme
Avastin Active Against Recurrent Glioblastoma.
NovoTTF Therapy Comparable to Chemotherapy for Glioblastoma Multiforme.
Gene Test Identifies Patients with Glioblastoma who Achieve Improved Survival with Temodar®
Novel Approach Shows Promise for Glioblastoma
Investigational Vaccine Promising in Glioblastoma
A combination of radiation and chemotherapy has show encouraging results for patients with malignant gliomas.
Chemotherapy Plus Radiation Extends Survival in Patients with Anaplastic Oligodendroglial Tumors
Link Between Cell Phone Use and Brain Tumors Remains Inconclusive
Small Vaccine Study Promising for Newly Diagnosed Glioblastoma Multiforme Patients
Dental X-rays Linked to Common Brain Tumor
Implanted Combination Therapy Shows Promise in Recurrent Glioblastoma
131-Im81C6 Promising for Recurrent Brain Tumors
Vaccine May Be Effective in Relapsed Glioma
Afinitor Approved for Treatment of Benign Brain Tumor
Abnormal Chromosome Influences Outcome of Rare Brain Tumor
Early Radiation Improves Progression-Free Survival in Low-Grade Brain Cancer
Recurrent High-grade Glioma Patients May Benefit from Hypofractionated Stereotactic Radiation Therapy
Rituxan® May Be Effective in Central Nervous System Lymphomas
Ludwig Cancer Research and Cancer Research Institute Evaluate Immunotherapeutic Strategies for Brain Cancer
Rindopepimut Continues to Show Promise Against Glioblastoma
Differences in IMRT Radiation Doses May Complicate Study Results in Brain Cancer
Chemotherapy Alone is Promising for Pediatric Medulloblastoma
Temsirolimus Promising for Treatment of Breast Cancer, Mantle Cell Lymphoma, and Glioblastoma
Combination of Gleevec® and Hydrea® Offers Promise for Glioblastoma Multiforme
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain
O6–BG May Help Re-Sensitize Cancer Cells to Temodar® in Brain Cancer
Predicting the Response of Glioblastoma to EGFR Inhibitors
Fluorescent-Guided Surgery May Allow For Greater Removal of Brain Tumors
Childhood Cancer Survivors Facing Cognitive Challenges May Benefit from Methylphenidate
No Overall Association Between Prenatal X-ray Exposure and Childhood Brain Tumors
Novel Vaccine May Improve Survival in Brain Cancer
Tarceva® Produces Responses in Recurrent Glioblastoma Multiforme.
Risk Factors Help Predict Survival Following Surgery for Recurrent Glioblastoma Multiforme
Radiation Modestly Improves Survival in Elderly with Glioblastoma.
Temodar® Approved by FDA for Newly Diagnosed Glioblastoma Patients
Understanding this complex disease and its treatment options
Continuous Temodar Shows Promise Against Recurrent Glioma
Oncophage® Cancer Vaccine Shows Promise Against Glioblastoma.
Exposure to Nerve Agents in Gulf War Increases Risk of Death from Brain Cancer in Veterans
Avastin® Improves Survival in Recurrent Brain Cancer
Chemotherapy Delays Need for Radiation in Children with Ependymoma
Addition of Temodar® to Radiation Therapy Improves Survival as Initial Therapy in Glioblastoma Multiforme.
No Survival Benefit of Adding Chemotherapy to Initial Treatment of Two Types of Brain Tumors
Tarceva® and Temodar® plus Radiation Improves Survival in Glioblastoma Multiforme.
Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme
Many Patients Not Receiving Chemotherapy for Gliomas
Gene Expression Profiling May Help Distinguish Types of Brain Tumors
Vaccination and Chemotherapy Appear to Work Together to Increase Survival in Patients with Glioblastoma
National Brain Cancer Awareness Month on CancerConnect
Avastin® Approved for Progressive Glioblastoma
Penn Study Suggests that Combining CAR T Cells with Existing Immunotherapies May Overcome Resistance in Glioblastomas
MP-470 Granted Orphan Drug Status for Glioblastoma.
CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Lee
Good Prognosis for Neuroblastoma Patients Diagnosed Before 18 Months of Age
Optune looking for others to share their experience? How long do you wear it each day? How…
Several trials for GBM and other brain cancers at MSKCC: they keep them updated here:…
New precision cancer medicine trials for brain tumors at UCSF:…
Update on polio virus clinical trial: UCSF;…
DCVAax trial update provided-still looks promising: …
"some evidence" that cell phones cause brain tumors in rats; https://www.nytimes…
SurVaxM is another novel vaccine for brain cancer being evaluated: SurVaxM stimulates the immune…
Dendritic cell vaccine-part of GBM treatment? https://www.medpagetoday…